Demonstrate Brand Value to the NHS

As the National Health Service (NHS) pursues its collective goal to produce healthcare results that lead the world, it is intensifying its emphasis on a group of far-reaching, critical objectives: reducing mortality and morbidity, increasing safety, and improving patient experience and outcomes. For pharmaceutical manufacturers, that acute focus on outcomes means that they will be measured – and, ultimately, compensated – based on the value for the money that their new medicines offer to discrete patient populations.

Whether first viewed as a business philosophy, a process, or a series of interconnected tactics, Managed Entry Services from Quintiles always point to the same result: A better understanding of the dynamics poised to influence market acceptance, delivered at a time when those insights can inform your launch strategies directed toward successful long-term brand adoption.